| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 1.504 | 2.704 | 5.627 | 4.234 | 0 | 13.613 | 37.880 | 66.271 | 122.438 |
| Total Income - EUR | 2.030 | 3.928 | 5.087 | 7.966 | 7.026 | 0 | 15.355 | 39.978 | 68.363 | 124.518 |
| Total Expenses - EUR | 2.924 | 7.348 | 3.727 | 7.894 | 6.479 | 0 | 16.015 | 38.748 | 65.814 | 128.755 |
| Gross Profit/Loss - EUR | -893 | -3.420 | 1.360 | 72 | 547 | 0 | -660 | 1.231 | 2.549 | -4.237 |
| Net Profit/Loss - EUR | -893 | -3.458 | 1.279 | -97 | 404 | 0 | -747 | 852 | 1.887 | -7.910 |
| Employees | 1 | 2 | 1 | 1 | 1 | 0 | 2 | 2 | 4 | 6 |
Check the financial reports for the company - Blutrot Medicine Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.706 | 16.969 | 14.299 | 11.697 | 8.719 | 8.554 | 41.410 | 37.509 | 37.648 | 32.193 |
| Current Assets | 2.286 | 323 | 302 | 849 | 618 | 591 | 2.058 | 5.642 | 13.499 | 19.016 |
| Inventories | 195 | 194 | 190 | 187 | 0 | 0 | 671 | 2.491 | 4.796 | 8.755 |
| Receivables | 0 | 0 | 0 | 193 | 0 | 0 | 344 | 660 | 5.452 | 0 |
| Cash | 2.091 | 129 | 112 | 469 | 618 | 591 | 1.043 | 2.491 | 3.251 | 10.261 |
| Shareholders Funds | -848 | -4.297 | -2.946 | -2.989 | -2.527 | -2.479 | -3.170 | -2.328 | -435 | -8.343 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.411 | 21.589 | 3.407 | 3.994 | 2.812 | 2.743 | 39.698 | 40.760 | 48.823 | 58.887 |
| Income in Advance | 19.430 | 16.807 | 14.140 | 11.541 | 9.052 | 8.880 | 6.941 | 4.865 | 2.759 | 664 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Blutrot Medicine Srl